Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.68M Buy
174,925
+131,835
+306% +$4.17M 0.02% 828
2025
Q4
$940K Sell
43,090
-19,043
-31% -$395K ﹤0.01% 1755
2025
Q3
$1.33M Buy
+62,133
New +$1.39M ﹤0.01% 1370
2025
Q2
Sell
-20,716
Closed -$758K 2582
2025
Q1
$758K Buy
+20,716
New +$713K ﹤0.01% 1261
2024
Q4
Sell
-42,933
Closed -$1.62M 2417
2024
Q3
$1.62M Buy
42,933
+8,634
+25% +$333K 0.01% 974
2024
Q2
$1.36M Buy
+34,299
New +$1.11M 0.01% 879
2023
Q4
Sell
-39,516
Closed -$1.24M 2297
2023
Q3
$1.24M Buy
+39,516
New +$1.24M 0.01% 858
2021
Q2
Sell
-4,967
Closed -$234K 2822
2021
Q1
$234K Buy
+4,967
New +$204K ﹤0.01% 2234
2020
Q4
Sell
-17,916
Closed -$586K 1825
2020
Q3
$586K Buy
+17,916
New +$758K 0.02% 805

Other funds holding ATEX

HRT Financial's ATEX Position: Q1 2026 in Review

HRT Financial increased its Anterix (ATEX) stake by 306% in Q1 2026, buying an estimated $4.17M and bringing the position to 174,925 shares worth $6.68M. The position accounts for 0.02% of the portfolio, ranked #828.

HRT Financial first reported a position in ATEX in Q3 2020 and has held it in 9 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • HRT Financial held 174,925 shares of Anterix worth $6.68M as of Q1 2026.
  • HRT Financial bought 131,835 Anterix shares in Q1 2026, an estimated $4.17M.
  • Anterix made up 0.02% of HRT Financial's portfolio in Q1 2026, its #828 holding.
  • HRT Financial first reported a position in Anterix in Q3 2020 and has held it in 9 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.